Cytogenomics of hexavalent chromium (Cr6+) exposed cells: A comprehensive review

Indian Journal of Medical Research

Volumn 139, Issue MAR, 2014, Pages 349-370

  Nigam, Akanksha ^a   Priya, Shivam ^a   Bajpai, Preeti ^a   Kumar, Sushil ^a  

^a INTEGRAL UNIVERSITY   (India)

Author keywords

Apoptosis; Chromate carcinogenesis; Chromium; Epigenetics; Genomics; Microarray

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 3; ALPHA TUBULIN; BUTYRATE RESPONSE FACTOR 1; CASEIN KINASE II; CASPASE 4; CELL CYCLE PROTEIN; CHROMIUM; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLINE; DICHROMATE POTASSIUM; GENOMIC DNA; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 2; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; TYROSINE KINASE RECEPTOR; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNINDEXED DRUG; BIOLOGICAL MARKER; CHROMIUM HEXAVALENT ION;

APOPTOSIS; BIOSYNTHESIS; CELL CYCLE REGULATION; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CYTOGENETICS; CYTOSKELETON; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; DRUG CARCINOGENICITY; DRUG EXPOSURE; ENERGY METABOLISM; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; LUNG CANCER; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE; ONCOGENE RAS; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; CELL DIFFERENTIATION; CELL FUNCTION; CELLS; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PHYSIOLOGICAL PHENOMENA; CELLS; CHROMIUM; CYTOGENETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 84899809353     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Sorahan T, Burges DC, Hamilton L, Harrington JM. Lung cancer mortality in nickel/chromium platers, 1946-95. Occup Environ Med 1998; 55: 236-42.
2. Olaguibel JM, Basomba A. Occupational asthma induced by chromium salts. Allergol Immunopathol (Madr) 1989; 17: 133-6.
3. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Ind Med 1990; 17: 189-215.
4. Machle W, Gregorius F. Cancer of the respiratory system in the United States chromate-producing industry. Public Health Rep 1948; 63: 1114-27.
5. Shelnutt SR, Goad P, Belsito D V. Dermatological toxicity of hexavalent chromium. Crit Rev Toxicol 2007; 37: 375-87.
6. Popper HH, Grygar E, Ingolic E, Wawschinek O. Cytotoxicity of chromium-III and, VI compounds. 1. In vitro studies using different cell culture systems. Inhal Toxicol 1993; 5: 345-69.
7. Trzeciak A, Kowalik J, Małecka-Panas E, Drzewoski J, Wojewódzka M, Iwaneńko T, et al. Genotoxicity of chromium in human gastric mucosa cells and peripheral blood lymphocytes evaluated by the single cell gel electrophoresis (comet assay). Med Sci Monit 2000; 6: 24-9.
8. Vaglenov A, Nosko M, Georgieva R, Carbonell E, Creus A, Marcos R. Genotoxicity and radioresistance in electroplating workers exposed to chromium. Mutat Res 1999; 446: 23-34.
9. Wise JP Sr, Wise SS, Little JE. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat Res 2002; 517: 221-9.
10. Wise SS, Holmes AL, Wise JP Sr. Particulate and soluble hexavalent chromium are cytotoxic and genotoxic to human lung epithelial cells. Mutat Res 2006; 610: 2-7.
11. Danadevi K, Rozati R, Banu BS, Grover P. Genotoxic evaluation of welders occupationally exposed to chromium and nickel using the Comet and micronucleus assays. Mutagenesis 2004; 19: 35-41.
12. Wise SS, Schuler JH, Holmes AL, Katsifs SP, Ketterer ME, Hartsock WJ, et al. Comparison of two particulate hexavalent chromium compounds: Barium chromate is more genotoxic than lead chromate in human lung cells. Environ Mol Mutagen 2004; 44: 156-62.
13. Xie H, Holmes AL, Wise SS, Huang S, Peng C, Wise JP Sr. Neoplastic transformation of human bronchial cells by lead chromate particles. Am J Respir Cell Mol Biol 2007; 37: 544-52.
14. Briggs JA, Briggs RC. Characterization of chromium effects on a rat liver epithelial cell line and their relevance to in vitro transformation. Cancer Res 1988; 48: 6484-90.
15. DiPaolo JA, Casto BC. Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 1979; 39: 1008-13.
16. Fradkin A, Janoff A, Lane BP, Kuschner M. In vitro transformation of BHK21 cells grown in the presence of calcium chromate. Cancer Res 1975; 35: 1058-63.
17. Kowalski LA, Tsang SS, Davison AJ. Arsenic and chromium enhance transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells. Cancer Lett 1996; 103: 65-9.
18. Xie H, Wise SS, Wise JP Sr. Defcient repair of particulate hexavalent chromium-induced DNA double strand breaks leads to neoplastic transformation. Mutat Res 2008; 649: 230-8.
19. Tsuda H, Kato K. Chromosomal aberrations and morphological transformation in hamster embryonic cells treated with potassium dichromate in vitro. Mutat Res 1977; 46: 87-94.
20. Zhitkovich A, Voitkun V, Kluz T, Costa M. Utilization of DNA-protein cross-links as a biomarker of chromium exposure. Environ Health Perspect 1998; 106 (Suppl 4): 969-74.
21. Macfe A, Hagan E, Zhitkovich A. Mechanism of DNA-protein cross-linking by chromium. Chem Res Toxicol 2010; 15: 23: 341-7.
22. Hu L, Liu X, Chervona Y, Yang F, Tang MS, Darzynkiewicz Z, et al. Chromium induces chromosomal instability, which is partly due to deregulation of BubR1 and Emi1, two APC/C inhibitors. Cell Cycle 2011; 10: 2373-9.
23. Takahashi Y, Kondo K, Ishikawa S, Uchihara H, Fujino H, Sawada N, et al. Microscopic analysis of the chromium content in the chromium-induced malignant and premalignant bronchial lesions of the rat. Environ Res 2005; 99: 267-72.
24. Reynolds M, Stoddard L, Bespalov I, Zhitkovich A. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res 2007; 35: 465-76.
25. Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS. K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer 2006; 8: 30-8.
26. Guerci A, Seoane A, Dulout FN. Aneugenic effects of some metal compounds assessed by chromosome counting in MRC-5 human cells. Mutat Res 2000; 469: 35-40.
27. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008; 21: 28-44.
28. Cheng RY, Hockman T, Crawford E, Anderson LM, Shiao YH. Epigenetic and gene expression changes related to transgenerational carcinogenesis. Mol Carcinog 2004; 40: 1-11.
29. Hirose T, Kondo K, Takahashi Y, Ishikura H, Fujino H, Tsuyuguchi M, et al. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog 2002; 33: 172-80.
30. Koshi K. Effects of fume particles from stainless steel welding on sister chromatid exchanges and chromosome aberrations in cultured Chinese hamster cells. Ind Health 1979; 17: 39-49.
31. Lai JS, Kuo HW, Liao FC, Lien CH. Sister chromatid exchange induced by chromium compounds in human lymphocytes. Int Arch Occup Environ Health 1998; 71: 550-3.
32. MacRae WD, Whiting RF, Stich HF. Sister chromatid exchanges induced in cultured mammalian cells by chromate. Chem Biol Interact 1979; 26: 281-6.
33. Deng C, Lee HH, Xian H, Yao M, Huang J, Ou B, et al. Chromosomal aberrations and sister chromatid exchanges of peripheral blood lymphocytes in Chinese electroplating workers: effect of nickel and chromium. J Trace Elem Exp Med 1988; 1: 57-62.
34. Gomez-Arroyo S, Altamirano M, Villalobos-Pietrini R. Sister-chromatid exchanges induced by some chromium compounds in human lymphocytes in vitro. Mutat Res 1981; 90: 425-31.
35. Coogan TP, Motz J, Snyder CA, Squibb KS, Costa M. Differential DNA-protein crosslinking in lymphocytes and liver following chronic drinking water exposure of rats to potassium chromate. Toxicol Appl Pharmacol 1991; 109: 60-72.
36. Izzotti A, Bagnasco M, Camoirano A, Orlando M, De Flora S. DNA fragmentation, DNA-protein crosslinks, postlabeled nucleotidic modifcations, and 8-hydroxy-2'-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of chromium (VI). Chemoprevention by oral N-acetylcysteine. Mutat Res 1998; 400: 233-44.
37. Merk O, Reiser K, Speit G. Analysis of chromate-induced DNA-protein crosslinks with the comet assay. Mutat Res 2000; 471: 71-80.
38. Ha L, Ceryak S, Patierno SR. Generation of S phase-dependent DNA double-strand breaks by Cr (VI) exposure: involvement of ATM in Cr (VI) induction of gamma-H2AX. Carcinogenesis 2004; 25: 2265-74.
39. Fornace AJ Jr, Seres DS, Lechner JF, Harris CC. DNA-protein cross-linking by chromium salts. Chem Biol Interact 1981; 36: 345-54.
40. Xie H, Holmes AL, Young JL, Qin Q, Joyce K, Pelsue SC, et al. Zinc chromate induces chromosome instability and DNA double strand breaks in human lung cells. Toxicol Appl Pharmacol 2009; 234: 293-9.
41. Ewis AA, Kondo K, Lee J, Tsuyuguchi M, Hashimoto M, Yokose T, et al. Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers. Am J Ind Med 2001; 40: 92-7.
42. Seoane AL, Guerci AM, Dulout FN. Malsegregation as a possible mechanism of aneuploidy induction by metal salts in MRC-5 human cells. Environ Mol Mutagen 2002; 40: 200-6.
43. Wakeman TP, Kim WJ, Callens S, Chiu A, Brown KD, Xu B. The ATM-SMC1 pathway is essential for activation of the chromium (VI)-induced S-phase checkpoint. Mutat Res 2004; 554: 241-51.
44. Rodrigues CF, Urbano AM, Matoso E, Carreira I, Almeida A, Santos P, et al. Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability. Mutat Res 2009; 670: 42-52.
45. Katabami M, Dosaka-Akita H, Mishina T, Honma K, Kimura K, Uchida Y, et al. Frequent cyclin D1 expression in chromate-induced lung cancers. Hum Pathol 2000; 31: 973-9.
46. Kondo K, Hino N, Sasa M, Kamamura Y, Sakiyama S, Tsuyuguchi M, et al. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophy Res Commun 1997; 239: 95-100.
47. Hanaoka T, Yamano Y, Katsuno N, Kagawa J, Ishizu S. Elevated serum levels of pantropic p53 proteins in chromium workers. Scand J Work Environ Health 1997; 23: 37-40.
48. Carlisle DL, Pritchard DE, Singh J, Owens BM, Blankenship LJ, Orenstein JM, et al. Apoptosis and P53 induction in human lung fbroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicol Sci 2000; 55: 60-8.
49. Bagchi D, Bagchi M, Stohs SJ. Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol Cell Biochem 2001; 222: 149-58.
50. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002; 180: 5-22.
51. Fan Y, Ovesen JL, Puga A. Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice. J Trace Elem Med Biol 2012; 26: 188-91.
52. Schnekenburger M, Talaska G, Puga A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol 2007; 27: 7089-101.
53. Takahashi Y, Kondo K, Hirose T, Nakagawa H, Tsuyuguchi M, Hashimoto M, et al. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog 2005; 42: 150-8.
54. Kondo K, Takahashi Y, Hirose Y, Nagao T, Tsuyuguchi M, Hashimoto M, et al. The reduced expression and aberrant methylation of p16 (INK4a) in chromate workers with lung cancer. Lung Cancer 2006; 53: 295-302.
55. Sun H, Zhou X, Chen H, Li Q, Costa M. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol 2009; 237: 258-66.
56. Shumilla JA, Broderick RJ, Wang Y, Barchowsky A. Chromium (VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J Biol Chem 1999; 274: 36207-12.
57. Kimura T. Molecular mechanisms of zinc-mediated induction and chromium (VI)-mediated inhibition of mouse Metallothionein-I gene transcription. J Health Sci 2010; 56: 161-6.
58. Klein CB, Su L, Bowser D, Leszczynska J. Chromate-induced epimutations in mammalian cells. Environ Health Perspect 2002; 110 (Suppl 5): 739-43.
59. Ha L, Ceryak S, Patierno SR. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J Biol Chem 2003; 278: 17885-94.
60. Wise SS, Holmes AL, Xie H, Thompson WD, Wise JP Sr. Chronic exposure to particulate chromate induces spindle assembly checkpoint bypass in human lung cells. Chem Res Toxicol 2006; 19: 1492-8.
61. Qian Y, Jiang BH, Flynn DC, Leonard SS, Wang S, Zhang Z, et al. Cr(VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions. Mol Cell Biochem 2001; 222: 199-204.
62. Hodges NJ, Smart D, Lee AJ, Lewis NA, Chipman JK. Activation of c-Jun N-terminal kinase in A549 lung carcinoma cells by sodium dichromate: role of dissociation of apoptosis signal regulating kinase-1 from its physiological inhibitor thioredoxin. Toxicology 2004; 197: 101-12.
63. Tessier DM, Pascal LE. Activation of MAP kinases by hexavalent chromium, manganese and nickel in human lung epithelial cells. Toxicol Lett 2006; 167: 114-21.
64. Chuang SM, Liou GY, Yang JL. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium (VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 2000; 21: 1491-500.
65. Chuang SM, Yang JL. Comparison of roles of three mitogen-activated protein kinases induced by chromium (VI) and cadmium in non-small-cell lung carcinoma cells. Mol Cell Biochem 2001; 222: 85-95.
66. O'Hara KA, Klei LR, Barchowsky A. Selective activation of Src family kinases and JNK by low levels of chromium (VI). Toxicol Appl Pharmacol 2003; 190: 214-23.
67. Chen L, Ovesen JL, Puga A, Xia Y. Distinct contributions of JNK and p38 to chromium cytotoxicity and inhibition of murine embryonic stem cell differentiation. Environ Health Perspect 2009; 117: 1124-30.
68. O'Hara KA, Vaghjiani RJ, Nemec AA, Klei LR, Barchowsky A. Cr (VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck. Biochem J 2007; 402: 261-9.
69. Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, et al. Participation of MAP kinase p38 and IkappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation. J Environ Pathol Toxicol Oncol 2000; 19: 231-8.
70. Lui K, Husler J, Ye J, Leonard SS, Cutler D, Chen F, et al. On the mechanism of Cr (VI)-induced carcinogenesis: dose dependence of uptake and cellular responses. Mol Cell Biochem 2001; 222: 221-9.
71. Kim YD, An SC, Oyama T, Kawamoto T, Kim H. Oxidative stress, hogg1 expression and NF-kappaB activity in cells exposed to low level chromium. J Occup Health 2003; 45: 271-7.
72. Zuo Z, Cai T, Li J, Zhang D, Yu Y, Huang C. Hexavalent chromium Cr (VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathway. Environ Health Perspect 2012; 120: 547-53.
73. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res 2006; 7: 128.
74. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290: L209-21.
75. Kishiro I, Kato S, Fuse D, Yoshida T, Machida S, Kaneko N. Clinical signifcance of vascular endothelial growth factor in patients with primary lung cancer. Respirology 2002; 7: 93-8.
76. Kaya A, Ciledag A, Gulbay BE, Poyraz BM, Celik G, Sen E, et al. The prognostic signifcance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respir Med 2004; 98: 632-6.
77. Cressey R, Wattananupong O, Lertprasertsuke N, Vinitketkumnuen U. Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 2005; 5:128.
78. Nemec AA, Barchowsky A. Signal transducer and activator of transcription 1 (STAT1) is essential for chromium silencing of gene induction in human airway epithelial cells. Toxicol Sci 2009; 110: 212-23.
79. Nemec AA, Zubritsky LM, Barchowsky A. Chromium (VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells. Chem Res Toxicol 2010; 23: 396-404.
80. Lal MA, Bae D, Camilli TC, Patierno SR, Ceryak S. AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells. Cell Cycle 2009; 8: 1589-602.
81. Alexopoulos EC, Cominos X, Trougakos IP, Lourda M, Gonos ES, Makropoulos V. Biological monitoring of hexavalent chromium and serum levels of the senescence biomarker apolipoprotein J/Clusterin in welders. Bioinorg Chem Appl 2008: 98: 632-6.
82. Ye J, Shi X. Gene expression profle in response to chromium-induced cell stress in A549 cells. Mol Cell Biochem 2001; 222: 189-97.
83. Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, Soucy NV, et al. Genomic and proteomic profling of responses to toxic metals in human lung cells. Environ Health Perspect 2003; 111: 825-35.
84. Sun H, Clancy HA, Kluz T, Zavadil J, Costa M. Comparison of gene expression profles in chromate transformed BEAS-2B cells. PLoS One 2011; 6: e17982.
85. Pritchard DE, Ceryak S, Ramsey KE, O'Brien TJ, Ha L, Fornsaglio JL, et al. Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure. Mol Cell Biochem 2005; 279: 169-81.
86. Gavin IM, Gillis B, Arbieva Z, Prabhakar BS. Identifcation of human cell responses to hexavalent chromium. Environ Mol Mutagen 2007; 48: 650-7.
87. Sellamuthu R, Umbright C, Chapman R, Leonard S, Li S, Kashon M, et al. Transcriptomics evaluation of hexavalent chromium toxicity in human dermal fbroblasts. J Carcinog Mutag 2011; 2: 1-8.
88. Izzotti A, Cartiglia C, Balansky R, D'Agostini F, Longobardi M, De Flora S. Selective induction of gene expression in rat lung by hexavalent chromium. Mol Carcinog 2002; 35: 75-84.
89. Kopec AK, Kim S, Forgacs AL, Zacharewski TR, Proctor DM, Harris MA, et al. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol 2012; 259: 13-26.
90. Hirvonen H, Hukkanen V, Salmi TT, Pelliniemi TT, Alitalo R. L-myc and N-myc in hematopoietic malignancies. Leuk Lymphoma 1993; 11: 197-205.
91. Zhang J, Xiao Y, Guo Y, Breslin P, Zhang S, Wei W et al Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice. Leukemia 2011; 25: 1857-68.
92. 6+ induced cell transformation and the associated genomic dysregulation. Environ Toxicol Pharmacol 2013; 36: 182-93.